275 related articles for article (PubMed ID: 6407143)
1. HLA and B-lymphocyte alloantigens in Gila River Indians.
Ensroth AF; Mann DL; Johnson AH; Knowler WC; Pettitt DJ; Bennett PH
Tissue Antigens; 1983 Mar; 21(3):198-207. PubMed ID: 6407143
[TBL] [Abstract][Full Text] [Related]
2. HLA class II variation in the Gila River Indian Community of Arizona: alleles, haplotypes, and a high frequency epitope at the HLA-DR locus.
Williams RC; McAuley JE
Hum Immunol; 1992 Jan; 33(1):29-38. PubMed ID: 1372303
[TBL] [Abstract][Full Text] [Related]
3. Study of HLA alloantigens of the Navajo Indians of North America. II. HLA-A, B, C, DR and other genetic markers.
Troup GM; Schanfield MS; Singaraju CH; Harvey RL; Jameson J; Capper J; Baker B
Tissue Antigens; 1982 Nov; 20(5):339-51. PubMed ID: 7157340
[TBL] [Abstract][Full Text] [Related]
4. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
[TBL] [Abstract][Full Text] [Related]
5. HLA-A, B, C, DR, MT, and MB antigens in recurrent aphthous stomatitis.
Gallina G; Cumbo V; Messina P; Caruso C
Oral Surg Oral Med Oral Pathol; 1985 Apr; 59(4):364-70. PubMed ID: 3873635
[TBL] [Abstract][Full Text] [Related]
6. Molecular identifications of HLA-DR4, MT3, and TB21 antigens on HLA-DR4 homozygous B cell lines.
Maeda H; Hirata R
J Immunol; 1984 Feb; 132(2):574-7. PubMed ID: 6418807
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR genotype risks in seropositive rheumatoid arthritis.
Legrand L; Lathrop GM; Marcelli-Barge A; Dryll A; Bardin T; Debeyre N; Poirier JC; Schmid M; Ryckewaert A; Dausset J
Am J Hum Genet; 1984 May; 36(3):690-9. PubMed ID: 6428222
[TBL] [Abstract][Full Text] [Related]
8. Histocompatibility antigens in polymyalgia rheumatica and giant cell arteritis.
Armstrong RD; Behn A; Myles A; Panayi GS; Welsh KI
J Rheumatol; 1983 Aug; 10(4):659-61. PubMed ID: 6413689
[TBL] [Abstract][Full Text] [Related]
9. HLA-DR matching: the impact on cadaveric renal transplantation. A single-center study.
Madsen M; Graugaard B; Fjeldborg O; Posborg V; Hansen HE; Lamm LU; Kissmeyer-Nielsen F
Scand J Urol Nephrol Suppl; 1981; 64():56-63. PubMed ID: 6815794
[No Abstract] [Full Text] [Related]
10. Strong association of HLA-DR2 and MT1 with idiopathic membranous nephropathy in Japan.
Hiki Y; Kobayashi Y; Itoh I; Kashiwagi N
Kidney Int; 1984 Jun; 25(6):953-7. PubMed ID: 6332232
[TBL] [Abstract][Full Text] [Related]
11. [HLA-A, B, C, and DR typing in rheumatoid polyarthritis].
Seignalet J; Blotman F; Simon L; Soustelle B
Rev Med Interne; 1984 Jun; 5(2):128-35. PubMed ID: 6591321
[TBL] [Abstract][Full Text] [Related]
12. HLA antigens in the Uitoto Indians and an urban population of Colombia.
Bernal JE; Duran C; Papiha SS
Hum Hered; 1988; 38(6):337-40. PubMed ID: 3246373
[TBL] [Abstract][Full Text] [Related]
13. Histocompatibility antigen combinations in rheumatoid arthritis.
Karsh J; Klippel JH; Mann DL; Reinertsen JL; Moutsopoulos HM; Johnson AH; Decker JL
Clin Exp Rheumatol; 1983; 1(1):11-5. PubMed ID: 6598099
[TBL] [Abstract][Full Text] [Related]
14. Next generation sequencing and the classical HLA loci in full heritage Pima Indians of Arizona: Defining the core HLA variation for North American Paleo-Indians.
Williams RC; Knowler WC; Shuldiner AR; Gosalia N; Van Hout C; Regeneron Genetics Center ; Hanson RL; Bogardus C; Baier LJ
Hum Immunol; 2019 Dec; 80(12):955-965. PubMed ID: 31706744
[TBL] [Abstract][Full Text] [Related]
15. Psoriatic arthritis: risk factors for patients with psoriasis - a study based on histocompatibility antigen frequencies.
Beaulieu AD; Roy R; Mathon G; Morissette J; Latulippe L; Lang JY; Mathieu JP; Brunet D; Hebert J; Archambault H
J Rheumatol; 1983 Aug; 10(4):633-6. PubMed ID: 6413688
[TBL] [Abstract][Full Text] [Related]
16. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
[TBL] [Abstract][Full Text] [Related]
17. Ulcerative colitis and HLA phenotype.
Cottone M; Bunce M; Taylor CJ; Ting A; Jewell DP
Gut; 1985 Sep; 26(9):952-4. PubMed ID: 3861473
[TBL] [Abstract][Full Text] [Related]
18. A new B-cell alloantigen, TB21, coded for in the HLA-D/DR region.
Maeda H; Juji T
Tissue Antigens; 1982 Nov; 20(5):327-34. PubMed ID: 6818712
[TBL] [Abstract][Full Text] [Related]
19. Identification of the MT3 molecule from HLA-DR4, 7, and w9 homozygous cell lines.
Mukai R; Suzuki M; Yabe T; Hamaguchi H; Maeda H
J Immunol; 1984 Dec; 133(6):3211-9. PubMed ID: 6436378
[TBL] [Abstract][Full Text] [Related]
20. Association of PLT specificity of alloreactive lymphocyte clones with HLA-DR, MB and MT determinants.
Zeevi A; Scheffel C; Annen K; Bass G; Marrari M; Duquesnoy RJ
Immunogenetics; 1982; 16(3):209-18. PubMed ID: 6183198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
